NCT02109549View on ClinicalTrials.gov

Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions
Non Small Cell Lung Cancer
Trial Locations (3)

1066 CX

The Netherlands Cancer Institute (NKI), Amsterdam

1105 AZ

AMC, Amsterdam

6229 ET

MAASTRO clinic, Maastricht

All Listed Sponsors
collaborator

Maastro Clinic, The Netherlands

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

lead

Maastricht Radiation Oncology

OTHER

NCT02109549 - Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients. | Biotech Hunter | Biotech Hunter